揭开干粉吸入器阻力与最佳患者护理相关性的神秘性
Toby G D Capstick1, Sanjay Gudimetla2, David S Harris3
1Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Clinical drug investigation
|January 10, 2024
概括
选择合适的吸入器设备对于管理呼吸系统疾病至关重要. 了解干粉吸入器 (DPI) 耐药性有助于为个体患者的需求选择最佳设备,并改善治疗结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 制药技术 制药技术 制药技术
- 生物医学工程 生物医学工程
背景情况:
- 吸入器设备的选择对于有效的呼吸道疾病管理至关重要.
- 关于吸入器阻力及其对设备选择的影响存在不确定性.
- 干粉吸入器 (DPI) 具有内部阻力,而压力计量剂量吸入器 (pMDI) 使用推进剂.
研究的目的:
- 澄清吸入器阻力在指导选择适当呼吸器器械方面的作用.
- 为了揭开神秘,干粉吸入器阻力如何影响患者的设备选择.
- 为基于耐药性,技术和患者偏好的个性化设备选择提供指导.
主要方法:
- 审查影响吸入器选择的因素,包括设备几何和配方参数.
- 分析主要指标,如DPI中的流量和压力下降.
- 考虑吸入器技术和患者偏好作为设备选择的关键因素.
主要成果:
- 在DPI中吸入器阻力主要由设备设计几何学决定,配方也发挥着作用.
- 流量和压力下降是评估DPI电阻的重要指标.
- 个性化设备选择,优化技术和患者偏好是改善遵守和结果的关键.
结论:
- 干粉吸入器的阻力是一个关键因素,应指导为个别患者选择最适合的设备.
- 优化吸入器技术和考虑患者偏好以及设备耐药性对于最大限度地提高治疗效益至关重要.
- 对吸入器选择的个性化方法提高了患者的坚持性,并导致了更好的呼吸系统疾病管理结果.
更多相关视频
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
874
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.7K
相关概念视频
01:23Inhaled Medications
271
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
271
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
208
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
208
01:17Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K